File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Chinese Medicines for Cancer Treatment from the Metabolomics Perspective

TitleChinese Medicines for Cancer Treatment from the Metabolomics Perspective
Authors
Keywordsmetabolomics
cancer metabolism
adjuvant therapie
Chinese medicines
Issue Date2020
PublisherIntechOpen
Citation
Chinese Medicines for Cancer Treatment from the Metabolomics Perspective. In Hozzein, WN (Ed.), Metabolomics: New Insights into Biology and Medicine. London: IntechOpen, 2020 How to Cite?
AbstractCancer is one of the most prevalent diseases all over the world with poor prognosis and the development of novel therapeutic strategies is still urgently needed. The large amount of successful experiences in fighting against cancer-like diseases with Chinese medicine has suggested it as a great source of alternative treatments to human cancers. Cancer cells have been shown to own a predominantly unique metabolic phenotype to facilitate their rapid proliferation. Metabolic reprogramming is a remarkable hallmark of cancer and therapies targeting cancer metabolism can be highly specific and effective. Based on the sophisticated study of small molecule metabolites, metabolomics can provide us valuable information on dynamically metabolic responses of living systems to certain environmental condition. In this chapter, we systematically reviewed recent studies on metabolism-targeting anticancer therapies based on metabolomics in terms of glucose, lipid, amino acid, and nucleotide metabolisms and other altered metabolisms, with special emphasis on the potential of metabolic treatment with pure compounds, herb extracts, and formulations from Chinese medicines. The trends of future development of metabolism-targeting anticancer therapies were also discussed. Overall, the elucidation of the underlying molecular mechanism of metabolism-targeting pharmacologic therapies will provide us a new insight to develop novel therapeutics for cancer treatment.
Persistent Identifierhttp://hdl.handle.net/10722/293838
ISBN

 

DC FieldValueLanguage
dc.contributor.authorGuo, W-
dc.contributor.authorTan, HYH-
dc.contributor.authorWang, N-
dc.contributor.authorFeng, Y-
dc.date.accessioned2020-11-23T08:22:31Z-
dc.date.available2020-11-23T08:22:31Z-
dc.date.issued2020-
dc.identifier.citationChinese Medicines for Cancer Treatment from the Metabolomics Perspective. In Hozzein, WN (Ed.), Metabolomics: New Insights into Biology and Medicine. London: IntechOpen, 2020-
dc.identifier.isbn9781789851274-
dc.identifier.urihttp://hdl.handle.net/10722/293838-
dc.description.abstractCancer is one of the most prevalent diseases all over the world with poor prognosis and the development of novel therapeutic strategies is still urgently needed. The large amount of successful experiences in fighting against cancer-like diseases with Chinese medicine has suggested it as a great source of alternative treatments to human cancers. Cancer cells have been shown to own a predominantly unique metabolic phenotype to facilitate their rapid proliferation. Metabolic reprogramming is a remarkable hallmark of cancer and therapies targeting cancer metabolism can be highly specific and effective. Based on the sophisticated study of small molecule metabolites, metabolomics can provide us valuable information on dynamically metabolic responses of living systems to certain environmental condition. In this chapter, we systematically reviewed recent studies on metabolism-targeting anticancer therapies based on metabolomics in terms of glucose, lipid, amino acid, and nucleotide metabolisms and other altered metabolisms, with special emphasis on the potential of metabolic treatment with pure compounds, herb extracts, and formulations from Chinese medicines. The trends of future development of metabolism-targeting anticancer therapies were also discussed. Overall, the elucidation of the underlying molecular mechanism of metabolism-targeting pharmacologic therapies will provide us a new insight to develop novel therapeutics for cancer treatment.-
dc.languageeng-
dc.publisherIntechOpen-
dc.relation.ispartofMetabolomics: New Insights into Biology and Medicine-
dc.subjectmetabolomics-
dc.subjectcancer metabolism-
dc.subjectadjuvant therapie-
dc.subjectChinese medicines-
dc.titleChinese Medicines for Cancer Treatment from the Metabolomics Perspective-
dc.typeBook_Chapter-
dc.identifier.emailTan, HYH: hyhtan@hku.hk-
dc.identifier.emailWang, N: ckwang@hku.hk-
dc.identifier.emailFeng, Y: yfeng@hku.hk-
dc.identifier.authorityWang, N=rp02075-
dc.identifier.authorityFeng, Y=rp00466-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.5772/intechopen.88924-
dc.identifier.hkuros320051-
dc.publisher.placeLondon-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats